1. Home
  2. IGC vs MI Comparison

IGC vs MI Comparison

Compare IGC & MI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • MI
  • Stock Information
  • Founded
  • IGC 2005
  • MI 2009
  • Country
  • IGC United States
  • MI Hong Kong
  • Employees
  • IGC N/A
  • MI N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • MI Catalog/Specialty Distribution
  • Sector
  • IGC Health Care
  • MI Consumer Discretionary
  • Exchange
  • IGC Nasdaq
  • MI Nasdaq
  • Market Cap
  • IGC 29.4M
  • MI 26.1M
  • IPO Year
  • IGC N/A
  • MI N/A
  • Fundamental
  • Price
  • IGC $0.33
  • MI $2.85
  • Analyst Decision
  • IGC Strong Buy
  • MI
  • Analyst Count
  • IGC 2
  • MI 0
  • Target Price
  • IGC $3.75
  • MI N/A
  • AVG Volume (30 Days)
  • IGC 380.9K
  • MI 87.0K
  • Earning Date
  • IGC 02-12-2025
  • MI 01-01-0001
  • Dividend Yield
  • IGC N/A
  • MI N/A
  • EPS Growth
  • IGC N/A
  • MI N/A
  • EPS
  • IGC N/A
  • MI 1.16
  • Revenue
  • IGC $1,183,000.00
  • MI $1,273,946.00
  • Revenue This Year
  • IGC N/A
  • MI N/A
  • Revenue Next Year
  • IGC $13.38
  • MI N/A
  • P/E Ratio
  • IGC N/A
  • MI $2.65
  • Revenue Growth
  • IGC N/A
  • MI N/A
  • 52 Week Low
  • IGC $0.27
  • MI $2.05
  • 52 Week High
  • IGC $0.91
  • MI $16.70
  • Technical
  • Relative Strength Index (RSI)
  • IGC 41.18
  • MI 40.76
  • Support Level
  • IGC $0.31
  • MI $2.75
  • Resistance Level
  • IGC $0.37
  • MI $3.50
  • Average True Range (ATR)
  • IGC 0.02
  • MI 0.34
  • MACD
  • IGC -0.00
  • MI 0.07
  • Stochastic Oscillator
  • IGC 28.17
  • MI 32.29

About IGC IGC Pharma Inc.

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

About MI NFT Limited

NFT Ltd Formerly Takung Art Co Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.

Share on Social Networks: